Ocrelizumab shows promise in MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Ocrelizumab shows promise in MS

Postby MSUK » Tue Nov 01, 2011 1:30 am

Image

An investigational biologic drug that deactivates antibody-producing B cells reduced gadolinium-enhancing T1 lesions in multiple sclerosis patients, potentially offering yet another treatment approach to the disease, researchers said.

After 24 weeks of the phase II trial, lesion burden as measured by MRI was reduced by 89% in 55 patients treated with a low dose ocrelizumab relative to the 54-patient placebo group (95% CI 68% to 97%), according to Ludwig Kappos, MD, of University Hospital in Basel, Switzerland, and colleagues.

Lesions were reduced by 96% in 55 patients receiving a high dose of the drug (95% CI 89% to 99%), the researchers reported online in The Lancet.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2188
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: Ocrelizumab shows promise in MS

Postby Daisy3 » Wed Nov 02, 2011 8:55 am

Does anyone have any more information on this drug?
The other half has been asked if he is interested in taking part in the study.
User avatar
Daisy3
Family Elder
 
Posts: 308
Joined: Tue Feb 09, 2010 4:00 pm

Re: Ocrelizumab shows promise in MS

Postby Manu » Mon Jan 30, 2012 5:34 am

I'll be starting in the phase III study on 7th feb 2012.

I read a lot of promissing things as being possible to hold down the attacks with 85-90%.

Best Regards,

Manu
Manu
Getting to Know You...
 
Posts: 21
Joined: Thu Jan 26, 2012 5:22 am
Location: Ruiselede Belgium


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service